107 related articles for article (PubMed ID: 2164540)
1. Systemic bone marrow disorders: characterization with proton chemical shift imaging.
Gückel F; Brix G; Semmler W; Zuna I; Knauf W; Ho AD; van Kaick G
J Comput Assist Tomogr; 1990; 14(4):633-42. PubMed ID: 2164540
[TBL] [Abstract][Full Text] [Related]
2. [NMR tomographic imaging of bone marrow infiltrates in malignant lymphoma].
Gückel F; Semmler W; Döhner H; Knauf W; Görich J; Ho AD; van Kaick G
Rofo; 1989 Jan; 150(1):26-31. PubMed ID: 2536492
[TBL] [Abstract][Full Text] [Related]
3. [MR tomography detection of bone marrow infiltration by malignant lymphomas].
Gückel F; Döhner H; Knauf W; Ho AD; Semmler W; van Kaick G
Onkologie; 1989 Aug; 12 Suppl 1():34-7. PubMed ID: 2685693
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging of bone marrow in lymphoproliferative disorders: correlation with bone marrow biopsy.
Döhner H; Gückel F; Knauf W; Semmler W; van Kaick G; Ho AD; Hunstein W
Br J Haematol; 1989 Sep; 73(1):12-7. PubMed ID: 2679859
[TBL] [Abstract][Full Text] [Related]
5. Proton chemical shift imaging of bone marrow for monitoring therapy in leukemia.
Gückel F; Brix G; Semmler W; Ho AD; Körbling M; Georgi M; van Kaick G
J Comput Assist Tomogr; 1990; 14(6):954-9. PubMed ID: 2229574
[TBL] [Abstract][Full Text] [Related]
6. [Bone marrow involvement in Hodgkin's disease: MR tomography and chemical-shift imaging].
Kauczor HU; Bentz M; Bischoff H; Gückel F; Döhner H; Brix G; van Kaick G
Rofo; 1993 Dec; 159(6):555-61. PubMed ID: 8298116
[TBL] [Abstract][Full Text] [Related]
7. Malignant lymphoma: bone marrow imaging versus biopsy.
Linden A; Zankovich R; Theissen P; Diehl V; Schicha H
Radiology; 1989 Nov; 173(2):335-9. PubMed ID: 2678249
[TBL] [Abstract][Full Text] [Related]
8. [Bone marrow scintigraphy and magnetic resonance tomography in malignant lymphomas: comparison with histologic results].
Linden A; Zankovich R; Theissen P; Schauerte G; Diehl V; Schicha H
Nuklearmedizin; 1989 Oct; 28(5):166-71. PubMed ID: 2813080
[TBL] [Abstract][Full Text] [Related]
9. The detection of bone marrow involvement by lymphoma using magnetic resonance imaging.
Shields AF; Porter BA; Churchley S; Olson DO; Appelbaum FR; Thomas ED
J Clin Oncol; 1987 Feb; 5(2):225-30. PubMed ID: 3806167
[TBL] [Abstract][Full Text] [Related]
10. Radiological reasoning: bone marrow changes on MRI.
Swartz PG; Roberts CC
AJR Am J Roentgenol; 2009 Sep; 193(3 Suppl):S1-4, Quiz S5-9. PubMed ID: 19696238
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow involvement by hodgkin and non-hodgkin lymphomas.
Zhang QY; Foucar K
Hematol Oncol Clin North Am; 2009 Aug; 23(4):873-902. PubMed ID: 19577173
[TBL] [Abstract][Full Text] [Related]
12. [The significance of bone marrow and liver puncture in malignant lymphomas].
Güller R; Senn HJ; Nagel GA; Gudat F; Gyr K
Schweiz Med Wochenschr; 1972 Mar; 102(10):318-23. PubMed ID: 4113779
[No Abstract] [Full Text] [Related]
13. Fatty replacement of bone marrow after radiation therapy for Hodgkin disease: quantification with chemical shift imaging.
Kauczor HU; Dieti B; Brix G; Jarosch K; Knopp MV; van Kaick G
J Magn Reson Imaging; 1993; 3(4):575-80. PubMed ID: 8347949
[TBL] [Abstract][Full Text] [Related]
14. Low field strength magnetic resonance imaging of bone marrow in patients with malignant lymphoma.
Richards MA; Webb JA; Jewell SE; Amess JA; Wrigley PF; Lister TA
Br J Cancer; 1988 Apr; 57(4):412-5. PubMed ID: 3390376
[TBL] [Abstract][Full Text] [Related]
15. [Bone marrow changes in Hodgkin's disease: MR tomography and chemical shift imaging].
Gückel F; Semmler W; Brix G; Bachert-Baumann P; Körbling M; Bihl H; van Kaick G
Rofo; 1989 Jun; 150(6):670-3. PubMed ID: 2544941
[TBL] [Abstract][Full Text] [Related]
16. Dixon quantitative chemical shift MRI for bone marrow evaluation in the lumbar spine: a reproducibility study in healthy volunteers.
Maas M; Akkerman EM; Venema HW; Stoker J; Den Heeten GJ
J Comput Assist Tomogr; 2001; 25(5):691-7. PubMed ID: 11584227
[TBL] [Abstract][Full Text] [Related]
17. The role of bone marrow biopsy and FDG-PET/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non-Hodgkin B-cell lymphoma and Hodgkin lymphoma. Accuracy in a multicenter series of 372 patients.
Chen-Liang TH; Martin-Santos T; Jerez A; Senent L; Orero MT; Remigia MJ; Muiña B; Romera M; Fernandez-Muñoz H; Raya JM; Fernandez-Gonzalez M; Lancharro A; Villegas C; Carlos Herrera J; Frutos L; Luis Navarro J; Uña J; Igua C; Sanchez-Vaño R; Cozar Mdel P; Contreras J; Sanchez-Blanco JJ; Perez-Ceballos E; Ortuño FJ
Am J Hematol; 2015 Aug; 90(8):686-90. PubMed ID: 25925613
[TBL] [Abstract][Full Text] [Related]
18. Hematologic bone marrow disorders: quantitative chemical shift MR imaging.
Rosen BR; Fleming DM; Kushner DC; Zaner KS; Buxton RB; Bennet WP; Wismer GL; Brady TJ
Radiology; 1988 Dec; 169(3):799-804. PubMed ID: 3187003
[TBL] [Abstract][Full Text] [Related]
19. Dixon quantitative chemical shift imaging is a sensitive tool for the evaluation of bone marrow responses to individualized doses of enzyme supplementation therapy in type 1 Gaucher disease.
Hollak C; Maas M; Akkerman E; den Heeten A; Aerts H
Blood Cells Mol Dis; 2001; 27(6):1005-12. PubMed ID: 11831867
[TBL] [Abstract][Full Text] [Related]
20. [Hematologic diseases simulating aleukemic leukemias].
Patakfalvi A; Brasch G; Gógl A
Z Gesamte Inn Med; 1967 May; 22(9):272-7. PubMed ID: 5631675
[No Abstract] [Full Text] [Related]
[Next] [New Search]
